Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Heil

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|February 28, 2018
An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two CitiesJason M Pogue, Emily L Heil, Paul Lephart, et al.
Pharmacotherapy|April 5, 2020
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile InfectionAna D Vega, Emily L Heil, Alison L Blackman, et al.
Jac-Antimicrobial Resistance|May 16, 2023
Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatientsJonathan D Baghdadi, Katherine E Goodman, Laurence S Magder, et al.
Mutagenesis|January 9, 2026
Using error-corrected sequencing for evaluating mutagenicity of molnupiravir in humansPage B McKinzie, Rutu R Valapil, Emily L Heil, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2019
Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft functionSari R Freedman, Bharath R Ravichandran, Brian M Masters, et al.
Pharmacotherapy|January 21, 2020
Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic ShockAnne M Masich, Shamir N Kalaria, Jeffrey P Gonzales, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2018
Making the change to area under the curve-based vancomycin dosingEmily L Heil, Kimberly C Claeys, Ryan P Mynatt, et al.
JAMA Network Open|July 2, 2024
Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream InfectionsSara M Karaba, Sara E Cosgrove, Jae Hyoung Lee, et al.
The Journal of Emergency Medicine|August 19, 2015
Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department AntibiogramMichelle C Hines, Tareq Al-Salamah, Emily L Heil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States HospitalsKatherine E Goodman, Jonathan D Baghdadi, Laurence S Magder, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|February 28, 2018
An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two CitiesJason M Pogue, Emily L Heil, Paul Lephart, et al.
Pharmacotherapy|April 5, 2020
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile InfectionAna D Vega, Emily L Heil, Alison L Blackman, et al.
Jac-Antimicrobial Resistance|May 16, 2023
Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatientsJonathan D Baghdadi, Katherine E Goodman, Laurence S Magder, et al.
Mutagenesis|January 9, 2026
Using error-corrected sequencing for evaluating mutagenicity of molnupiravir in humansPage B McKinzie, Rutu R Valapil, Emily L Heil, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2019
Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft functionSari R Freedman, Bharath R Ravichandran, Brian M Masters, et al.
Pharmacotherapy|January 21, 2020
Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic ShockAnne M Masich, Shamir N Kalaria, Jeffrey P Gonzales, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2018
Making the change to area under the curve-based vancomycin dosingEmily L Heil, Kimberly C Claeys, Ryan P Mynatt, et al.
JAMA Network Open|July 2, 2024
Extended-Infusion β-Lactam Therapy, Mortality, and Subsequent Antibiotic Resistance Among Hospitalized Adults With Gram-Negative Bloodstream InfectionsSara M Karaba, Sara E Cosgrove, Jae Hyoung Lee, et al.
The Journal of Emergency Medicine|August 19, 2015
Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department AntibiogramMichelle C Hines, Tareq Al-Salamah, Emily L Heil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2022
Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States HospitalsKatherine E Goodman, Jonathan D Baghdadi, Laurence S Magder, et al.
Pageof 12